[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.114.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 7, 1994

A Randomized Controlled Trial of Influenza Vaccine in the ElderlyScientific Scrutiny and Ethical Responsibility

Author Affiliations

From the Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Md.

JAMA. 1994;272(21):1700-1701. doi:10.1001/jama.1994.03520210084039
Abstract

Influenza viruses have arguably caused more morbidity and mortality than any infectious agent in recorded history. Seven pandemics of influenza have occurred during the past century alone, one of which—the infamous Spanish (swine) flu—was responsible for at least 20 million deaths worldwide. Of even greater concern has been the occurrence of annual epidemics of varying severity that have resulted in more than 599 000 excess deaths in the United States during the past 40 years.1-3 Although complacency regarding influenza is widely prevalent owing to the misperception that it is simply a mild respiratory or gastrointestinal infection,2 one needs only to briefly examine accounts of recent outbreaks to appreciate the explosive potential for influenza viruses to cause life-threatening illness.4 The unusual properties of the virus' genome, including a high frequency of point mutations (which cause the hemagglutinin [HA] and neuraminidase [NA] molecules to drift

See also p 1661.

First Page Preview View Large
First page PDF preview
First page PDF preview
×